Sponsor pipeline

TCM Biotech International Corp. clinical trial pipeline

Get alerts when TCM Biotech International Corp.'s trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

3 trials changed in the last 30 days: 1 stopped, 0 with notable changes, 2 with minor changes only.

Stopped

PTX-9908 Injection for Non-resectable HCC With TACE

Trial status changed: Recruiting → Withdrawn

Also in this update: Study completion moved earlier from Dec 30, 2026 to Aug 14, 2026

TCM Biotech International Corp.Phase 1/2 NCT03812874 Registry history of NCT03812874 on ClinicalTrials.gov (opens the registry)

Oct 2, 2026

Show 2 trials with minor changes only

Minor

LivPhcD Capsules in the NAFLD Subjects

Trial completed

Also in this update: Study completion date changed from estimate of May 1, 2026 to Jan 22, 2026

TCM Biotech International Corp.Not applicable NCT05930093 Registry history of NCT05930093 on ClinicalTrials.gov (opens the registry)

Oct 2, 2026
Minor

U101 · U101 Oral Capsules · Uncomplicated rUTIs in Women

Trial sites expanded: 13 → 18 locations

TCM Biotech International Corp.Phase 3 NCT07184827 Registry history of NCT07184827 on ClinicalTrials.gov (opens the registry)

Oct 2, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 3

1

Get alerts when TCM Biotech International Corp.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free